Dr. Lim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Barnes West Dr
# Dv
Saint Louis, MO 63141Phone+1 800-647-2098Fax+1 314-362-3192
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2009 - 2010
- National Taiwan University College of MedicineClass of 1999
Certifications & Licensure
- MO State Medical License 2013 - 2025
- IL State Medical License 2020 - 2023
- MD State Medical License 2010 - 2014
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 3 citationsCombined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer.Ashenafi Bulle, Peng Liu, Kuljeet Seehra, Sapana Bansod, Yali Chen
Nature Communications. 2024-03-20 - Chemokine Receptor 2 Targeted PET/CT Imaging Distant Metastases in Pancreatic Ductal Adenocarcinoma.Xiaohui Zhang, Lisa Detering, Gyu Seong Heo, Deborah Sultan, Hannah Luehmann
ACS Pharmacology & Translational Science. 2024-01-12 - 2 citationsCombining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carc...Yige Wu, Siqi Chen, Xiaolu Yang, Kazuhito Sato, Preet Lal
Cancer Research. 2023-12-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: